✦ LIBER ✦

Metabolism and transporter-mediated drug–drug interactions of the endothelin-A receptor antagonist CI-1034

✍ Scribed by Jasminder Sahi; Michael W. Sinz; Scott Campbell; Rouchelle Mireles; Xianxian Zheng; Kelly A. Rose; Shamsi Raeissi; Muhammed F. Hashim; Yuyang Ye; Sonia M. de Morais; Christopher Black; Meera Tugnait; Laurence H. Keller

Book ID: 113517312
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 322 KB
Volume: 159
Category: Article
ISSN: 0009-2797
DOI: 10.1016/j.cbi.2005.11.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of CYP3A5 Expression on the Inhib

Effect of CYP3A5 Expression on the Inhibition of CYP3A-Catalyzed Drug Metabolism: Impact on Modeling CYP3A-Mediated Drug-Drug Interactions

✍ Shirasaka, Y.; Chang, S.-Y.; Grubb, M. F.; Peng, C.-C.; Thummel, K. E.; Isoherra 📂 Article 📅 2013 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 889 KB

Differential modulation of the expressio

Differential modulation of the expression of important drug metabolising enzymes and transporters by endothelin-1 receptor antagonists ambrisentan and bosentan in vitro

✍ Johanna Weiss; Melanie Herzog; Walter Emil Haefeli 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 920 KB

Carrier-Mediated Transport of H1-Antagon

Carrier-Mediated Transport of H1-Antagonist at the Blood-Brain Barrier: A Common Transport System of H1-Antagonists and Lipophilic Basic Drugs

✍ Masahiro Yamazaki; Tetsuya Terasaki; Kuniaki Yoshioka; Osamu Nagata; Hideo Kato; 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 504 KB